Hannafon BN - Search Results

1

Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.

Dogra S, Elayapillai SP, Qu D, Pitts K, Filatenkov A, Houchen CW, Berry WL, Moxley K, Hannafon BN. Dogra S, et al. Among authors: hannafon bn. Cancer Lett. 2023 Dec 1;578:216437. doi: 10.1016/j.canlet.2023.216437. Epub 2023 Oct 12. Cancer Lett. 2023. PMID: 37838282 Free PMC article.

2

Zinc at sub-cytotoxic concentrations induces heme oxygenase-1 expression in human cancer cells.

Xue J, Wang S, Wu J, Hannafon BN, Ding WQ. Xue J, et al. Among authors: hannafon bn. Cell Physiol Biochem. 2013;32(1):100-10. doi: 10.1159/000350128. Epub 2013 Jul 12. Cell Physiol Biochem. 2013. PMID: 23868099 Free PMC article.

3

Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).

Hannafon BN, Carpenter KJ, Berry WL, Janknecht R, Dooley WC, Ding WQ. Hannafon BN, et al. Mol Cancer. 2015 Jul 16;14:133. doi: 10.1186/s12943-015-0400-7. Mol Cancer. 2015. PMID: 26178901 Free PMC article.

4

Breast Cancer Microenvironment Cross Talk through Extracellular Vesicle RNAs.

Dogra S, Hannafon BN. Dogra S, et al. Among authors: hannafon bn. Am J Pathol. 2021 Aug;191(8):1330-1341. doi: 10.1016/j.ajpath.2021.03.014. Epub 2021 Apr 22. Am J Pathol. 2021. PMID: 33895121 Free article. Review.

5

Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.

Undi RB, Ahsan N, Larabee JL, Darlene-Reuter N, Papin J, Dogra S, Hannafon BN, Bronze MS, Houchen CW, Huycke MM, Ali N. Undi RB, et al. Among authors: hannafon bn. J Virol. 2023 Nov 30;97(11):e0119423. doi: 10.1128/jvi.01194-23. Epub 2023 Oct 20. J Virol. 2023. PMID: 37861336 Free PMC article.

6

OKN-007 is an Effective Anticancer Therapeutic Agent Targeting Inflammatory and Immune Metabolism Pathways in Endometrial Cancer.

Elayapillai SP, Gandhi A, Dogra S, Saunders D, Smith N, Hladik C, Towner RA, Moxley KM, Hannafon BN. Elayapillai SP, et al. Among authors: hannafon bn. J Pharmacol Exp Ther. 2024 Jul 19:JPET-AR-2024-002223. doi: 10.1124/jpet.124.002223. Online ahead of print. J Pharmacol Exp Ther. 2024. PMID: 39029957 Free article.

7

ATR inhibition increases reliance on PARP-mediated DNA repair revealing an improved therapeutic strategy for cervical cancer.

Elayapillai SP, Dogra S, Lausen J, Parker M, Kennedy A, Benbrook DM, Moxley KM, Hannafon BN. Elayapillai SP, et al. Among authors: hannafon bn. Gynecol Oncol. 2024 Dec;191:182-193. doi: 10.1016/j.ygyno.2024.10.009. Epub 2024 Oct 19. Gynecol Oncol. 2024. PMID: 39427557

8

Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria.

Liu T, Hannafon B, Gill L, Kelly W, Benbrook D. Liu T, et al. Mol Cancer Ther. 2007 Jun;6(6):1814-22. doi: 10.1158/1535-7163.MCT-06-0279. Mol Cancer Ther. 2007. PMID: 17575110 Free PMC article.

9

Plasma exosome microRNAs are indicative of breast cancer.

Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ. Hannafon BN, et al. Breast Cancer Res. 2016 Sep 8;18(1):90. doi: 10.1186/s13058-016-0753-x. Breast Cancer Res. 2016. PMID: 27608715 Free PMC article.

10

Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1.

Jiao Y, Watts T, Xue J, Hannafon B, Ding WQ. Jiao Y, et al. BMC Cancer. 2018 Oct 26;18(1):1042. doi: 10.1186/s12885-018-4946-9. BMC Cancer. 2018. PMID: 30367621 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters